ocular drug delivery advances challenges and applications
Ocular Drug Delivery: Advances, Challenges and Applications
$225.00 Original price was: $225.00.$4.99Current price is: $4.99. Add to cart
Sale!

Ocular Drug Delivery: Advances, Challenges and Applications

Original price was: $225.00.Current price is: $4.99.

-98%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

The Pharmacologic Barrier: Ocular Drug Delivery

The human eye is an impenetrable fortress, designed by evolution to actively flush out foreign substances via tears and block molecular entry via the blood-retinal barrier. Delivering therapeutic drugs to the retina without them being washed away or blocked is a massive pharmacological challenge. Ocular Drug Delivery: Advances, Challenges and Applications is a fiercely technical, heavily biochemical masterwork detailing the vanguard of ocular pharmacology. This volume provides the exact blueprints required to force medication into the most heavily defended organ in the body.

Mastering the Intravitreal Injection

The core philosophy of this text is bypassing the barriers. The authors aggressively detail the physics of direct intraocular delivery. It dictates exactly how the transition to monthly intravitreal injections (stabbing a needle directly into the eye) revolutionized the treatment of macular degeneration, bypassing the cornea entirely to deliver anti-VEGF antibodies directly to the dying retina.

Navigating Sustained Release

The book provides a masterclass in advanced bioengineering. It dictates the exact molecular pathways for sustained drug release. It rigorously covers the development of surgically implanted, biodegradable polymer sustained-release reservoirs (like the Ozurdex implant) that slowly elute corticosteroids into the vitreous over six months, freeing the patient from the nightmare of daily eye drops.

Frequently Asked Questions (FAQs)

Is this a clinical manual telling me which eye drops to prescribe?
No, it is a highly advanced *pharmacology and bioengineering* text focusing on the *mechanisms* of how drugs are delivered, formulated, and absorbed by the eye.

Who is the primary audience?
It is the absolute, mandatory definitive reference for Ocular Pharmacologists, Biotech Researchers, and Academic Ophthalmologists.